Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer
Titel:
Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer
Auteur:
S., Prakash S. Nagarkar, Rajnish Vasant Puligundla, Krishna Chaitanya N., Lokesh K. Boya, Rakesh Reddy Patel, Ankit Baldevbhai Goyal, Lovenish Thoke, Aniket Patel, Jigar Gordhanbhai Mehta, Ajay Omprakash Patel, Ghanshyam Nanubhai Khan, Mujtaba A. Ahmad, Imran